Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Agilon Health (AGL)
NYSE:AGL
Agilon Health (AGL) Stock Price & Analysis
209 Followers
AGL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.41 - $21.52
Previous Close$6.75
Volume1.37M
Average Volume (3M)4.49M
Market Cap
$2.79B
Enterprise Value$2.33B
Total Cash (Recent Filing)$488.34M
Total Debt (Recent Filing)$38.56M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Aug 06, 2024EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding411,261,609
10 Day Avg. Volume3,514,599
30 Day Avg. Volume4,486,159
Standard Deviation0.19
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)4.67
Price to Sales (P/S)3.29
Price to Cash Flow (P/CF)-11.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit33.38
Enterprise Value/Ebitda1.27K
Forecast
1Y Price Target
$6.63Price Target Upside-2.36% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Agilon Health News
PremiumCompany Announcements
Agilon Health Welcomes Jeff Schwaneke as New CFO
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAGL reported solid 1Q24 results with reported adjusted EBITDA of $29 million beating consensus of $15 million.
LeadershipAGL announced that it had named Jeff Schwaneke as its new chief financial officer; Mr. Schwaneke has 15 years of experience in managed care, including serving as CFO of Centene, which is viewed positively given the central core competency of underwriting in both managed care and full-risk value-based care.
Management StrategyManagement's contract exits demonstrate a more prudent approach and, coupled with some recent negotiated payor premium increases, warrant credit for management's proactive approach to assess the viability of existing contracts.
Bears Say
EarningsEstimates are trimmed following 1Q24 results, which were affected by negative PYD.
Medical MarginMedical margin in Q1 was below the guidance midpoint, with negative PYD partially offset by relief on 2023 medical expenses from payer negotiations.
Membership GuidanceAGL expects to exit unprofitable payor contracts during 2Q, resulting in the lowering of MA membership guidance to a range of 510K-515K, down from prior guidance of 540K-550K.
---
Ownership Overview
26.21% Insiders
52.53% Mutual Funds
11.59% Other Institutional Investors
9.66% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AGL FAQ
What was Agilon Health’s price range in the past 12 months?
Agilon Health lowest stock price was $4.41 and its highest was $21.52 in the past 12 months.
What is Agilon Health’s market cap?
Currently, no data Available
When is Agilon Health’s upcoming earnings report date?
Agilon Health’s upcoming earnings report date is Aug 06, 2024 which is in 11 days.
How were Agilon Health’s earnings last quarter?
Agilon Health released its earnings results on May 07, 2024. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.013 by $0.023.
Is Agilon Health overvalued?
According to Wall Street analysts Agilon Health’s price is currently Overvalued.
Does Agilon Health pay dividends?
Agilon Health does not currently pay dividends.
What is Agilon Health’s EPS estimate?
Agilon Health’s EPS estimate is -$0.07.
How many shares outstanding does Agilon Health have?
Agilon Health has 411,261,600 shares outstanding.
What happened to Agilon Health’s price movement after its last earnings report?
Agilon Health reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.013. Following the earnings report the stock price went up 4.217%.
Which hedge fund is a major shareholder of Agilon Health?
Among the largest hedge funds holding Agilon Health’s share is Clayton, Dubilier & Rice, Llc. It holds Agilon Health’s shares valued at 610M.
---
Agilon Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.63 (-2.36% Downside)
$6.63 (-2.36% Downside)
Blogger Sentiment
Neutral
AGL Sentiment 84%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 75.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.98%
12-Months-Change
Fundamentals
Return on Equity
-23.94%
Trailing 12-Months
Asset Growth
6.74%
Trailing 12-Months
Company Description
Agilon Health
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
---
AGL Earnings Call
Q1 2024
0:00 / 0:00
---
AGL Stock 12 Month Forecast
Average Price Target
$6.63
▼(-2.36% Downside)
Technical Analysis
Best Analysts Covering AGL
1 Year
1 Year Success Rate
3/15 ratings generated profit
1 Year Average Return
-36.07%
reiterated a buy rating 3 months ago
Copying Steve Baxter's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -36.07% per trade.
---